Europe Interventional Oncology Market Size & Outlook

The interventional oncology market in Europe is expected to reach a projected revenue of US$ 1,771.8 million by 2033. A compound annual growth rate of 8.8% is expected of Europe interventional oncology market from 2026 to 2033.
Revenue, 2025 (US$M)
$902.0
Forecast, 2033 (US$M)
$1,771.8
CAGR, 2026 - 2033
8.8%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe interventional oncology market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe interventional oncology market highlights

  • The Europe interventional oncology market generated a revenue of USD 902.0 million in 2025.
  • The market is expected to grow at a CAGR of 8.8% from 2026 to 2033.
  • In terms of segment, ablation therapies was the largest revenue generating technique in 2025.
  • Ablation Therapies is the most lucrative technique segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.


Europe data book summary

Market revenue in 2025USD 902.0 million
Market revenue in 2033USD 1,771.8 million
Growth rate8.8% (CAGR from 2026 to 2033)
Largest segmentAblation therapies
Fastest growing segmentAblation Therapies
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAblation Therapies, Embolization Therapies, Biopsy Techniques, Targeted Therapy Delivery Systems, Image-Guided Procedures
Key market players worldwideMedtronic PLC, Boston Scientific Corp, Johnson & Johnson, Baxter International Inc, Cook Medical, AngioDynamics Inc, Stryker Corp, B. Braun Medical, Terumo Corp, Siemens Healthineers AG ADR, GE HealthCare Technologies Inc Common Stock, Becton Dickinson & Co


Other key industry trends

  • In terms of revenue, Europe region accounted for 31.2% of the global interventional oncology market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,219.6 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Interventional Oncology Market Companies

Name Profile # Employees HQ Website
AngioDynamics Inc View profile 815 14 Plaza Drive, Latham, NY, United States, 12110 https://www.angiodynamics.com
Cook Medical View profile 10001+ Bloomington, Indiana, United States, North America http://www.cookmedical.com
B. Braun Medical View profile 10001+ Bethlehem, Pennsylvania, United States, North America http://www.bbraunusa.com
Terumo Corp View profile 30207 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 https://www.terumo.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
Boston Scientific Corp View profile 48000 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 https://www.bostonscientific.com
Stryker Corp View profile 52000 1941 Stryker Way, Portage, MI, United States, 49002 https://www.stryker.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com
Becton Dickinson & Co View profile 73000 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 https://www.bd.com
GE HealthCare Technologies Inc Common Stock View profile 51000 500 West Monroe Street, Chicago, IL, United States, 60661 https://www.gehealthcare.com
Baxter International Inc View profile 60000 One Baxter Parkway, Deerfield, IL, United States, 60015 https://www.baxter.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

Europe interventional oncology market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional oncology market will help companies and investors design strategic landscapes.


Ablation therapies was the largest segment with a revenue share of 42.35% in 2025. Horizon Databook has segmented the Europe interventional oncology market based on ablation therapies, embolization therapies, biopsy techniques, targeted therapy delivery systems, image-guided procedures covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Europe interventional oncology market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe interventional oncology market databook

  • Our clientele includes a mix of interventional oncology market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe interventional oncology market , including forecasts for subscribers. This continent databook contains high-level insights into Europe interventional oncology market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe interventional oncology market size, by country, 2021-2033 (US$M)

Europe Interventional Oncology Market Outlook Share, 2025 & 2033 (US$M)

Europe interventional oncology market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online